Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Debopam Samanta

Concepts (335)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
29
2025
181
13.270
Why?
Anticonvulsants
19
2025
125
8.240
Why?
Seizures
24
2025
198
6.320
Why?
Tuberous Sclerosis
8
2025
37
4.390
Why?
Spasms, Infantile
11
2025
29
4.270
Why?
Cannabidiol
8
2025
41
4.050
Why?
Status Epilepticus
6
2021
36
3.350
Why?
Epilepsies, Myoclonic
5
2024
12
3.120
Why?
Mutation
16
2023
1275
3.110
Why?
Deep Brain Stimulation
4
2025
43
2.850
Why?
Humans
116
2025
50417
2.700
Why?
Electroencephalography
18
2024
304
2.530
Why?
Intellectual Disability
5
2023
121
2.210
Why?
Brain
10
2024
1318
2.150
Why?
Child
41
2025
6931
2.140
Why?
Hemiplegia
3
2021
11
2.020
Why?
Developmental Disabilities
5
2019
119
1.700
Why?
Epilepsy, Absence
3
2019
11
1.650
Why?
Magnetic Resonance Imaging
16
2025
1546
1.620
Why?
Genetic Therapy
2
2025
120
1.500
Why?
Infant
23
2025
3648
1.460
Why?
Algorithms
2
2025
624
1.430
Why?
Tumor Suppressor Proteins
3
2023
127
1.410
Why?
Neuroaxonal Dystrophies
2
2022
8
1.400
Why?
Nervous System Malformations
3
2020
17
1.390
Why?
Folate Receptor 1
2
2022
25
1.370
Why?
Infant, Newborn, Diseases
2
2020
56
1.280
Why?
Epilepsies, Partial
2
2022
12
1.280
Why?
Ketamine
2
2020
59
1.270
Why?
Child, Preschool
21
2025
3953
1.200
Why?
Vagus Nerve Stimulation
2
2025
14
1.170
Why?
Neurocutaneous Syndromes
2
2019
6
1.150
Why?
Cadherins
2
2019
61
1.130
Why?
Cerebral Arteries
2
2019
37
1.060
Why?
Epilepsy, Generalized
2
2023
8
1.040
Why?
Vigabatrin
3
2024
3
1.030
Why?
Sirolimus
2
2017
61
1.020
Why?
Angiofibroma
2
2015
5
0.990
Why?
Facial Neoplasms
2
2015
22
0.970
Why?
Nerve Tissue Proteins
2
2018
192
0.960
Why?
Valproic Acid
2
2022
31
0.950
Why?
Male
36
2025
25867
0.920
Why?
Stroke
3
2019
495
0.920
Why?
Randomized Controlled Trials as Topic
2
2024
567
0.910
Why?
Fenfluramine
2
2024
8
0.910
Why?
Female
32
2025
27053
0.900
Why?
Dioxolanes
2
2024
14
0.890
Why?
Thalamus
1
2024
38
0.890
Why?
Pregnanolone
2
2023
6
0.870
Why?
Treatment Outcome
12
2025
5265
0.850
Why?
Landau-Kleffner Syndrome
1
2022
3
0.820
Why?
Quality Improvement
2
2022
215
0.790
Why?
Aphasia
1
2022
33
0.780
Why?
Nervous System Diseases
2
2021
89
0.760
Why?
Chromosome Deletion
3
2019
134
0.750
Why?
Abnormalities, Multiple
3
2023
166
0.750
Why?
Emergencies
1
2021
78
0.720
Why?
Pharmaceutical Preparations
1
2021
77
0.710
Why?
Angelman Syndrome
1
2020
1
0.700
Why?
Transition to Adult Care
1
2020
17
0.700
Why?
Bone Diseases, Developmental
2
2023
14
0.680
Why?
Tooth Abnormalities
2
2023
12
0.680
Why?
Immunoglobulins, Intravenous
1
2021
64
0.670
Why?
Oligonucleotides, Antisense
1
2020
26
0.670
Why?
Phenobarbital
1
2020
17
0.670
Why?
Behavioral Symptoms
1
2019
3
0.660
Why?
Immunologic Factors
1
2021
113
0.660
Why?
Flunarizine
1
2019
1
0.660
Why?
Excitatory Amino Acid Antagonists
1
2020
50
0.660
Why?
Ocular Physiological Phenomena
1
2019
4
0.650
Why?
Tetrasomy
1
2019
2
0.650
Why?
Chromosomes, Human, Pair 5
1
2019
15
0.640
Why?
Agenesis of Corpus Callosum
2
2018
11
0.640
Why?
Sneddon Syndrome
1
2019
3
0.640
Why?
Livedo Reticularis
1
2019
5
0.640
Why?
Oral Ulcer
1
2019
3
0.640
Why?
Calcium Channel Blockers
1
2019
63
0.630
Why?
Behcet Syndrome
1
2019
7
0.630
Why?
Transposases
1
2019
10
0.630
Why?
Andersen Syndrome
1
2019
1
0.630
Why?
Spinal Cord Diseases
1
2019
36
0.620
Why?
Hydrocephalus
1
2019
43
0.620
Why?
Receptors, GABA-B
1
2019
11
0.620
Why?
Vitiligo
1
2019
8
0.620
Why?
Leukoencephalopathies
1
2019
14
0.620
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.620
Why?
Nephrotic Syndrome
2
2017
18
0.620
Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.610
Why?
Migraine Disorders
2
2020
45
0.610
Why?
Edema
1
2019
69
0.610
Why?
Cerebral Infarction
1
2018
37
0.610
Why?
Alopecia
1
2019
29
0.610
Why?
Electron Transport Complex IV
1
2018
28
0.610
Why?
Muscle Weakness
1
2019
44
0.600
Why?
Physicians
1
2022
235
0.600
Why?
Cannabinoid Receptor Agonists
1
2019
51
0.600
Why?
Optic Atrophy
1
2018
16
0.600
Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.600
Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.600
Why?
Photic Stimulation
1
2018
55
0.600
Why?
Shab Potassium Channels
1
2018
2
0.600
Why?
Parents
1
2021
320
0.590
Why?
Brain Edema
1
2018
38
0.590
Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
27
0.580
Why?
Autoimmune Diseases
1
2019
78
0.580
Why?
Thrombocytopenia
1
2019
82
0.580
Why?
Myoclonus
1
2018
9
0.580
Why?
Artifacts
1
2018
54
0.580
Why?
Biomedical Research
1
2021
243
0.580
Why?
Mitochondrial Diseases
1
2018
41
0.580
Why?
Adolescent
14
2025
6453
0.570
Why?
Neurodegenerative Diseases
1
2018
74
0.570
Why?
Practice Guidelines as Topic
1
2020
473
0.560
Why?
Health Knowledge, Attitudes, Practice
1
2021
485
0.550
Why?
Hearing Loss, Sensorineural
1
2018
76
0.550
Why?
Osteochondrodysplasias
1
2017
12
0.550
Why?
Models, Biological
1
2020
717
0.540
Why?
Immunologic Deficiency Syndromes
1
2017
19
0.540
Why?
Infant, Newborn
6
2024
2752
0.540
Why?
Phenotype
2
2021
736
0.540
Why?
Arteriosclerosis
1
2017
53
0.540
Why?
Carotid Artery Diseases
1
2017
33
0.540
Why?
Drug Discovery
1
2017
84
0.530
Why?
Child Development
1
2018
192
0.520
Why?
Prenatal Exposure Delayed Effects
1
2018
185
0.520
Why?
Skin
1
2019
382
0.520
Why?
Cafe-au-Lait Spots
1
2016
2
0.510
Why?
Erythema Infectiosum
1
2015
3
0.500
Why?
Williams Syndrome
1
2016
26
0.500
Why?
Migraine with Aura
1
2015
4
0.500
Why?
Corpus Callosum
2
2023
28
0.500
Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.500
Why?
Syndrome
6
2024
236
0.500
Why?
Sinus Pericranii
1
2015
1
0.500
Why?
Parvovirus B19, Human
1
2015
17
0.500
Why?
Pulmonary Embolism
1
2017
99
0.500
Why?
Toes
1
2015
14
0.500
Why?
Electrodiagnosis
1
2015
12
0.490
Why?
SOS1 Protein
1
2015
2
0.490
Why?
Crying
1
2015
4
0.490
Why?
Moyamoya Disease
1
2015
7
0.490
Why?
Iatrogenic Disease
1
2015
23
0.490
Why?
Hyperventilation
1
2015
8
0.490
Why?
Tuberculoma
1
2015
2
0.490
Why?
Epilepsy, Benign Neonatal
1
2015
2
0.490
Why?
Noonan Syndrome
1
2015
12
0.490
Why?
Neurologic Examination
1
2015
75
0.490
Why?
Encephalitis
1
2016
40
0.490
Why?
Communication
3
2022
256
0.480
Why?
Ocular Motility Disorders
1
2015
17
0.480
Why?
Mutism
1
2015
3
0.480
Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.480
Why?
TOR Serine-Threonine Kinases
1
2015
76
0.480
Why?
Repressor Proteins
2
2023
149
0.470
Why?
Diagnosis, Differential
7
2020
1029
0.470
Why?
Trisomy
1
2014
27
0.470
Why?
Influenza, Human
1
2015
86
0.460
Why?
KCNQ2 Potassium Channel
1
2014
9
0.460
Why?
Energy Drinks
1
2014
6
0.450
Why?
Neurology
1
2015
42
0.450
Why?
Vasoconstriction
1
2014
56
0.450
Why?
Benzodiazepines
1
2014
70
0.450
Why?
Osteomyelitis
1
2015
125
0.440
Why?
Membrane Proteins
1
2016
337
0.440
Why?
Sleep
1
2014
183
0.420
Why?
Enzyme Inhibitors
1
2015
369
0.420
Why?
Quality of Life
4
2025
850
0.400
Why?
Magnetic Resonance Angiography
3
2019
71
0.400
Why?
Immunosuppressive Agents
3
2019
227
0.390
Why?
Consensus
2
2025
159
0.380
Why?
Pediatrics
1
2015
285
0.380
Why?
Receptors, N-Methyl-D-Aspartate
2
2022
126
0.340
Why?
Diffusion Magnetic Resonance Imaging
3
2017
124
0.340
Why?
Clinical Trials as Topic
2
2024
488
0.340
Why?
Caregivers
2
2021
223
0.320
Why?
Recurrence
3
2019
657
0.310
Why?
Echinocandins
1
2008
64
0.300
Why?
Mycoses
1
2008
159
0.280
Why?
Gastroesophageal Reflux
2
2019
47
0.270
Why?
Retrospective Studies
7
2025
6274
0.270
Why?
Antifungal Agents
1
2008
342
0.250
Why?
Administration, Topical
2
2015
67
0.250
Why?
Adult
6
2025
13561
0.240
Why?
Seizures, Febrile
1
2024
3
0.230
Why?
Meta-Analysis as Topic
1
2024
38
0.230
Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
Why?
Databases, Factual
2
2024
676
0.220
Why?
Psychosurgery
1
2023
4
0.220
Why?
Laser Therapy
1
2023
83
0.210
Why?
Speech Disorders
1
2022
16
0.200
Why?
Ethosuximide
1
2022
5
0.200
Why?
Clonazepam
1
2022
6
0.200
Why?
Electrodes, Implanted
1
2022
30
0.200
Why?
Cluster Analysis
1
2023
209
0.200
Why?
Stereotaxic Techniques
1
2022
38
0.200
Why?
Death, Sudden
1
2022
10
0.190
Why?
GTPase-Activating Proteins
1
2022
23
0.190
Why?
Palliative Care
1
2024
191
0.190
Why?
Concept Formation
1
2021
12
0.190
Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
Why?
Freedom
1
2021
3
0.190
Why?
Diazepam
1
2021
17
0.190
Why?
Folic Acid
1
2022
141
0.190
Why?
Drug Interactions
1
2022
207
0.180
Why?
Fibroma
1
2021
39
0.180
Why?
Risk Factors
2
2020
3712
0.180
Why?
Adrenocorticotropic Hormone
2
2022
31
0.180
Why?
Personal Satisfaction
1
2021
76
0.180
Why?
Soft Tissue Neoplasms
1
2021
54
0.180
Why?
Brain Diseases
1
2021
83
0.180
Why?
Dihydroergotamine
1
2020
4
0.180
Why?
Mental Disorders
1
2025
418
0.170
Why?
Perception
1
2021
115
0.170
Why?
Transcription Factors
2
2023
561
0.170
Why?
Facies
2
2023
33
0.170
Why?
Diet Therapy
1
2020
8
0.170
Why?
Genetic Diseases, Inborn
1
2020
20
0.170
Why?
Clinical Protocols
1
2020
111
0.170
Why?
Treatment Failure
1
2020
120
0.160
Why?
Anesthetics
1
2020
36
0.160
Why?
Ubiquitin-Protein Ligases
1
2020
93
0.160
Why?
Leukomalacia, Periventricular
1
2019
12
0.160
Why?
Learning
1
2021
155
0.160
Why?
Muscle Hypotonia
1
2019
21
0.160
Why?
Chromosomes, Human, Pair 7
1
2019
29
0.160
Why?
Patient-Centered Care
1
2021
130
0.160
Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
Why?
HLA-B51 Antigen
1
2019
2
0.160
Why?
Qualitative Research
1
2021
351
0.160
Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
Why?
Craniofacial Abnormalities
1
2019
27
0.160
Why?
Ventriculoperitoneal Shunt
1
2019
26
0.160
Why?
Heart Septal Defects, Atrial
1
2019
46
0.160
Why?
Disease Management
1
2020
179
0.160
Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
Why?
Ventricular Premature Complexes
1
2019
7
0.160
Why?
Microcephaly
1
2019
39
0.160
Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
Why?
Facial Nerve Diseases
1
2018
6
0.150
Why?
Referral and Consultation
1
2021
287
0.150
Why?
Syncope
1
2019
29
0.150
Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
Why?
Cerebral Veins
1
2018
15
0.150
Why?
Facial Paralysis
1
2018
23
0.150
Why?
Anti-Arrhythmia Agents
1
2019
80
0.150
Why?
Deglutition Disorders
1
2019
77
0.150
Why?
Health Personnel
1
2021
251
0.150
Why?
Acute Disease
1
2019
374
0.150
Why?
Fatal Outcome
1
2019
197
0.150
Why?
Video Recording
1
2018
84
0.150
Why?
Fibrinolytic Agents
1
2019
125
0.150
Why?
Frameshift Mutation
1
2018
16
0.150
Why?
Combined Modality Therapy
1
2020
640
0.140
Why?
Anti-Inflammatory Agents
1
2019
165
0.140
Why?
Fear
1
2018
83
0.140
Why?
India
1
2017
52
0.140
Why?
Platelet Aggregation Inhibitors
1
2019
174
0.140
Why?
Cerebellum
1
2018
132
0.140
Why?
History, 21st Century
1
2017
57
0.140
Why?
History, 20th Century
1
2017
100
0.140
Why?
Neurotoxicity Syndromes
1
2017
45
0.140
Why?
Methotrexate
1
2017
76
0.140
Why?
Pandemics
1
2021
553
0.130
Why?
Animals
3
2022
13062
0.130
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
82
0.130
Why?
Anti-Infective Agents
1
2017
99
0.130
Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
Why?
Hormones
1
2016
57
0.130
Why?
Influenza B virus
1
2015
4
0.130
Why?
Delayed Diagnosis
1
2016
24
0.130
Why?
Arkansas
1
2021
1974
0.120
Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
Why?
North America
1
2015
65
0.120
Why?
Cerebral Angiography
1
2015
97
0.120
Why?
Antibiotics, Antineoplastic
1
2015
77
0.120
Why?
Chromosomes, Human, Pair 9
1
2014
13
0.120
Why?
Brain Waves
1
2014
16
0.120
Why?
Complementary Therapies
1
2015
26
0.120
Why?
Drug Resistance
1
2015
65
0.120
Why?
Antiemetics
1
2014
31
0.110
Why?
Polymerase Chain Reaction
1
2015
447
0.110
Why?
Headache
1
2014
74
0.110
Why?
Glutamine
1
2015
175
0.110
Why?
Mutation, Missense
1
2014
103
0.110
Why?
Vomiting
1
2014
71
0.110
Why?
Arginine
1
2015
185
0.110
Why?
Decision Making, Computer-Assisted
1
2013
4
0.100
Why?
Analgesics
1
2014
117
0.100
Why?
Diagnostic Errors
1
2013
66
0.100
Why?
Evidence-Based Medicine
1
2013
254
0.090
Why?
Inflammation
1
2016
607
0.090
Why?
Pregnancy
1
2018
2444
0.090
Why?
Signal Transduction
1
2017
1608
0.090
Why?
Antineoplastic Agents
1
2017
1165
0.080
Why?
Dysentery
1
2009
1
0.080
Why?
Trichuriasis
1
2009
1
0.080
Why?
Trichuris
1
2009
1
0.080
Why?
Anesthesia, Intravenous
1
2008
12
0.080
Why?
Eosinophils
1
2009
40
0.080
Why?
Lipopeptides
1
2008
63
0.070
Why?
Amyloidosis
1
2009
79
0.070
Why?
Inflammatory Bowel Diseases
1
2009
53
0.070
Why?
Tuberculosis
1
2009
131
0.070
Why?
Candidiasis
1
2008
112
0.070
Why?
Aspergillosis
1
2008
125
0.070
Why?
Kidney Diseases
1
2009
213
0.070
Why?
Prospective Studies
2
2023
2378
0.060
Why?
Clinical Trials, Phase III as Topic
1
2025
47
0.060
Why?
Spasm
1
2024
9
0.060
Why?
Observer Variation
1
2024
138
0.050
Why?
Feedback
1
2024
53
0.050
Why?
Kaplan-Meier Estimate
1
2025
462
0.050
Why?
Probability
1
2023
163
0.050
Why?
Young Adult
2
2025
4075
0.050
Why?
Neuroimaging
1
2023
86
0.050
Why?
Neurosurgical Procedures
1
2024
126
0.050
Why?
Potassium Channels
1
2021
33
0.050
Why?
Registries
1
2024
565
0.040
Why?
Reproducibility of Results
1
2024
1181
0.040
Why?
Administration, Intravenous
1
2020
70
0.040
Why?
Sleep Stages
1
2020
41
0.040
Why?
Age of Onset
1
2020
109
0.040
Why?
Cognition
1
2022
342
0.040
Why?
Follow-Up Studies
1
2025
2231
0.040
Why?
Immunohistochemistry
1
2021
955
0.040
Why?
Aged
1
2025
9738
0.020
Why?
Software
1
2013
268
0.020
Why?
Internet
1
2013
259
0.020
Why?
Middle Aged
1
2025
12579
0.020
Why?
Antinematodal Agents
1
2009
2
0.020
Why?
Mebendazole
1
2009
2
0.020
Why?
Leukemoid Reaction
1
2009
6
0.020
Why?
Antitubercular Agents
1
2009
103
0.020
Why?
Colonoscopy
1
2009
100
0.020
Why?
Prognosis
1
2009
1974
0.010
Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description